SCHEMBL6529328

SCHEMBL6529328

C=CN1CCC(CCCCC)C1=O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.35
CHRNB2 P17787 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
ALDH1A1 P00352 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
S1PR1 P21453 2/20 0.31
S1PR3 Q99500 2/20 0.31
S1PR5 Q9H228 2/20 0.31
FAAH O00519 1/20 0.31
ACHE P22303 1/20 0.31
GNAI3 P08754 1/20 0.30
GNAO1 P09471 1/20 0.30
GNAI1 P63096 1/20 0.30
CCR6 P51684 1/20 0.30
EPHX1 P07099 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30593904 0.98 CYP1A2 (0.37) CYP1A2CHRNB2CHRNA7CHRNA4ALDH1A1
SCHEMBL26698417 0.98 CYP1A2 (0.37) CYP1A2CHRNB2CHRNA7CHRNA4ALDH1A1
SCHEMBL17895159 0.98 CYP1A2 (0.37) CYP1A2CHRNB2CHRNA7CHRNA4ALDH1A1
SCHEMBL1741079 0.98 CYP1A2 (0.37) CYP1A2CHRNB2CHRNA7CHRNA4ALDH1A1
SCHEMBL22731769 0.98 CYP1A2 (0.37) CYP1A2CHRNB2CHRNA7CHRNA4ALDH1A1
SCHEMBL11668569 0.98 CYP1A2 (0.37) CYP1A2CHRNB2CHRNA7CHRNA4ALDH1A1
SCHEMBL531034 0.95 ALDH1A1 (0.33) ALDH1A1FAAHACHECCR6PKM
SCHEMBL20136144 0.89 CHRNB2 (0.37) CYP1A2CHRNB2CHRNA7CHRNA4ALDH1A1
SCHEMBL3365506 0.88
SCHEMBL21449079 0.88 FAAH (0.35) FAAHACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936632-B2 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof MERCKLE GMBH (DE) 2005-08-30 US disclosed
US-20040122002-A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof MERCKLE GMBH (DE) 2004-06-24 US disclosed
EP-1246825-B1 FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF MERCKLE GMBH (DE) 2003-12-17 EP disclosed
EP-1246825-A1 FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF MERCKLE GMBH (DE) 2002-10-09 EP disclosed
WO-2001051491-A1 FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF MERCKLE GMBH (DE) 2001-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122002-A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof PTGS1, PTGS2, PTGER1 CYP1A2 35/4885CHRNB2 4582/4885CHRNA7 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.